Aldifen

N/A

Report date: 2025/05/13 16:53:20

Base Information

Drug NameAldifen
Drug Alias NamenitrofendinofannitropheneMP101MP-101 +[6] 
ClassificationSmall molecules
Mechanisms of ActionMitochondrial proteins modulatorsBrain-derived neurotrophic factor expression modulators
TargetsMitochondrial proteinsBrain-derived neurotrophic factor
Therapy Area/IndicationsAmyotrophic Lateral SclerosisHuntington DiseaseMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEU
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMitochon Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesMitochon Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral SclerosisHuntington DiseaseMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A